Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochem Cell Biol ; 98(2): 267-276, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31013436

RESUMEN

BACKGROUND: This study focuses on the lncRNA XIST (X inactive-specific transcript), an lncRNA involved in multiple human cancers, and investigates the functional significance of XIST and the molecular mechanisms underlying the epithelial-mesenchymal transition (EMT) in pancreatic cancer (PC). METHODS: Clinical specimens from 25 patients as well as 5 human PC cell lines were analyzed for XIST, YAP, and microRNA(miR)-34a by quantitative real-time PCR (qRT-PCR) and immunohistochemistry. To investigate how XIST influences cell proliferation, invasiveness, and apoptosis in PC, we performed the CCK-8 assays, Transwell assays, and flow cytometry. Luciferase reporter assays, qRT-PCR, and Western blot were applied to prove that miR-34a directly binds to XIST. RESULTS: Up-regulation of XIST and Yes associated protein (YAP) and down-regulation of miR-34a were consistently observed in the clinical specimens and PC cell lines. Silencing XIST reduced the expression of YAP and suppressed transforming growth factor (TGF)-ß1-induced EMT, while over-expression of XIST increased the expression of YAP and promoted EMT. In addition, inhibition of epidermal growth factor receptor (EGFR) hampered the XIST-promoted EMT. The results from the luciferase reporter assays confirmed that miR-34a directly targets XIST and suggested that XIST regulates cell proliferation, invasiveness, and apoptosis in PC by sponging miR-34a. CONCLUSIONS: XIST promotes TGF-ß1-induced EMT by regulating the miR-34a-YAP-EGFR axis in PC.


Asunto(s)
Transición Epitelial-Mesenquimal , Regulación Neoplásica de la Expresión Génica , Neoplasias Pancreáticas/metabolismo , ARN Largo no Codificante/genética , Factor de Crecimiento Transformador beta1/metabolismo , Apoptosis , Línea Celular Tumoral , Proliferación Celular , Receptores ErbB/metabolismo , Femenino , Células HEK293 , Humanos , Masculino , MicroARNs/metabolismo , Invasividad Neoplásica , Fenotipo , Pronóstico
2.
Small ; 11(21): 2499-504, 2015 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-25613059

RESUMEN

Supramolecular nanosubstrate-mediated delivery (SNSMD) leverages the power of molecular self-assembly and a nanostructured substrate platform for the low toxicity, highly efficient co-delivery of biological factors encapsulated in a nanovector. Human fibroblasts are successfully reprogrammed into induced pluripotent stems and transdifferentiated into induced neuronal-like cells.


Asunto(s)
Transdiferenciación Celular , Técnicas de Reprogramación Celular/métodos , Reprogramación Celular , Línea Celular , Transdiferenciación Celular/genética , Reprogramación Celular/genética , Fibroblastos/citología , Fibroblastos/metabolismo , Técnicas de Transferencia de Gen , Vectores Genéticos , Humanos , Nanocápsulas , Nanotecnología , Polimorfismo de Nucleótido Simple
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA